The results of the in vivo tumor growth inhibition assay, qRT-PCR, and Western blot analysis also initially demonstrated the inhibitory efficacy of the nanobubbles carrying AR siRNA against C4-2 xenograft tumors. This evidence concerns the gene AR and neoplasm.